market analysis

Award, fellowship & grant

Molecules, Mentors & Mindsets

Market Reports

Taltz Biosimilar Landscape: Three Ixekizumab Programs Enter the Race

Market Reports

Will Reblozyl Continue to See the Thinnest Biosimilar Competitive Intensity? | Ounsh Ventures

Market Reports

Enhertu Biosimilars: Is the $15 Billion ADC Market Worth the Risk? | Market Report

Market Reports

Dupixent Biosimilars: $30 Billion Opportunity or High-Risk Investment? | Market Report

Mentor Konnect

How Cells Relay Mechanical Signals to Drive Long-Range Directional Migration

November 5, 2026

lncRNA TAAL Regulates TIE1 and Protects Blood Vessel Integrity in Diabetic Retinopathy

November 2, 2026

CTE Prevalence in Former NFL Players: New Study Estimates 74.5%

November 1, 2026